Indication

RIDA®QUICK ADM Monitoring is a rapid test for adalimumab drug concentration monitoring which supports timely dose adjustments in clinical practice. A poster about the validation of the test was [...]

Clostridium difficile is one of the most frequent pathogens in nosocomial infections – but in spite of this many people have never heard of it. Since November is officially “Clostridium [...]

The year’s wet and cold season begins in October along with the annual flu season. After an extraordinarily severe flu wave in 2017/18, experts are warning that the flu should not be [...]

Chronic inflammatory diseases like Crohn’s disease, ulcerative colitis, and rheumatism respond well to treatment with the TNF-α blockers infliximab and adalimumab. Monitoring the [...]

More than half of the world’s population suffers from an inflammation of the gastric mucosa called gastritis. These patients are at risk of developing a gastric ulcer, a duodenal ulcer or even [...]

Now that summer is here, people are spending more and more time outside. Warm temperatures certainly make activities like swimming, hiking, jogging and picnicking more attractive. But forests and [...]

The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.

Sexually transmitted infections/diseases (STIs or STDs) like syphilis, gonorrhea, and chlamydia are on the rise worldwide. But hardly anyone talks about it. To mark STD Awareness Month, we [...]

R-Biopharm AG today announced that it has entered into a collaboration with Bosch Healthcare Solutions. Under the agreement, R‑Biopharm AG develops, manufactures and commercializes molecular [...]